Self-sampling of blood using a topper and pediatric tubes; a prospective feasibility study for PSA analysis using 120 prostate cancer patients
- PMID: 37314986
- DOI: 10.1515/cclm-2023-0272
Self-sampling of blood using a topper and pediatric tubes; a prospective feasibility study for PSA analysis using 120 prostate cancer patients
Abstract
Objectives: Self-collection of blood for diagnostic purposes by blood collection assist devices (BCAD) has gained a lot of momentum. Nonetheless, there are a lack of studies demonstrating the feasibility and reliability of self-collecting capillary blood for routine (immuno)chemistry testing. In this study we describe the topper technology together with pediatric tubes to enable self-collection of blood and investigated its feasibility for PSA testing by prostate cancer patients.
Methods: A total of 120 prostate cancer patients for which a routine follow-up PSA test was requested, were included in this study. Patients received instruction materials and the blood-collection device consisting of a topper, pediatric tube and base-part, and performed the blood collection procedure themselves. Afterwards a questionnaire was filled-in. Finally, PSA was measured on a Roche Cobas Pro.
Results: The overall self-sampling success rate was 86.7 %. Furthermore, when specified per age category, a 94.7 % success rate for patients under 70 years and a 25 % success rate for patients of 80 years and older was observed. Venous and self-collected PSA were highly comparable when analyzed by Passing-Bablok regression with a slope of 0.99 and intercept of 0.00011, Spearmans correlation coefficient (0.998) and average self-collected PSA recovery of 99.8 %.
Conclusions: Evidence is presented that self-collected capillary blood by topper and pediatric tube from the finger is feasible, particularly for patients under 70 years. Furthermore, capillary blood self-sampling did not compromise any of the PSA test results. Future validation in a real-world setting, without supervision and including sample stability and logistics, is required.
Keywords: PSA; capillary blood collection; direct to consumer testing; self-collection.
© 2023 the author(s), published by De Gruyter, Berlin/Boston.
References
-
- Stoffel, M, Greene, DN, Beal, SG, Foley, P, Killeen, AA, Shafi, H, et al.. Direct-to-Consumer testing for routine purposes. Clin Chem 2022;68:1121–7. https://doi.org/10.1093/clinchem/hvac106 . - DOI
-
- Rockwell, KL. Direct-to-Consumer medical testing in the era of value-based care. JAMA 2017;317:2485–6. https://doi.org/10.1001/jama.2017.5929 . - DOI
-
- Li, M, Diamandis, EP, Grenache, D, Joyner, MJ, Holmes, DT, Seccombe, R. Direct-to-Consumer testing. Clin Chem 2017;63:635–41. https://doi.org/10.1373/clinchem.2016.260349 . - DOI
-
- Hendelman, T, Chaudhary, A, LeClair, AC, van Leuven, K, Chee, J, Fink, SL, et al.. Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS One 2021;16:e0255841. https://doi.org/10.1371/journal.pone.0255841 . - DOI
-
- Bateman, KP. The development of patient-centric sampling as an enabling technology for clinical trials. Bioanalysis 2020;12:971–6. https://doi.org/10.4155/bio-2020-0075 . - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous